Michael Hisbergues
Overview
Explore the profile of Michael Hisbergues including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brocard G, Casey R, Dufay N, Marignier R, Michel L, Hisbergues M, et al.
Mult Scler Relat Disord
. 2023 Jul;
77:104872.
PMID: 37453261
Today's medicine strives to be personalized, preventive, predictive and participatory. This implies to have access to multimodal data to better characterize patients groups and to combine clinical and imaging data...
2.
Alidjinou E, Demaret J, Corroyer-Simovic B, Vuotto F, Miczek S, Labreuche J, et al.
Clin Microbiol Infect
. 2022 Oct;
29(2):258.e1-258.e4.
PMID: 36257549
Objectives: We investigated serum neutralizing activity against BA.1 and BA.2 Omicron sublineages and T cell response before and 3 months after administration of the booster vaccine in healthcare workers (HCWs)....
3.
Beauval N, Leroyer A, Hisbergues M, Allorge D, Maboudou P, Howsam M, et al.
J Trace Elem Med Biol
. 2022 Sep;
74:127080.
PMID: 36179463
Background: Analysis of urinary trace elements is widely used in Human Biology, especially in occupational and environmental biomonitoring. Collections of urine samples are of great interest for those studying trace...
4.
Alidjinou E, Demaret J, Corroyer-Simovic B, Labreuche J, Goffard A, Trauet J, et al.
Lancet Reg Health Eur
. 2022 Apr;
17:100385.
PMID: 35469147
Background: The present study aimed to evaluate the persistent immunogenicity offered by a third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) residents. Methods: In this...
5.
Demaret J, Corroyer-Simovic B, Alidjinou E, Goffard A, Trauet J, Miczek S, et al.
Front Immunol
. 2021 Dec;
12:778679.
PMID: 34868051
Long-term care facility (LTCF) older residents display physiological alterations of cellular and humoral immunity that affect vaccine responses. Preliminary reports suggested a low early postvaccination antibody response against severe acute...
6.
Hisbergues M, Vendeville S, Vendeville P
J Biomed Mater Res B Appl Biomater
. 2008 Jun;
88(2):519-29.
PMID: 18561291
Currently, zirconia is widely used in biomedical area as a material for prosthetic devices because of its good mechanical and chemical properties. Largely employed in clinical area for total hip...
7.
Han W, Mercenier A, Ait-Belgnaoui A, Pavan S, Lamine F, van Swam I, et al.
Inflamm Bowel Dis
. 2006 Nov;
12(11):1044-52.
PMID: 17075345
The use of superoxide dismutases (SODs) in inflammatory diseases is hampered by their short circulatory half-life. To determine whether a bacterial supply of SOD into the colon might improve an...
8.
Pearson L, Hisbergues M, Borner T, Dittmann E, Neilan B
Appl Environ Microbiol
. 2004 Nov;
70(11):6370-8.
PMID: 15528494
The cyanobacterium Microcystis aeruginosa is widely known for its production of the potent hepatotoxin microcystin. Microcystin is synthesized nonribosomally by the thiotemplate function of a large, modular enzyme complex encoded...
9.
Via-Ordorika L, Fastner J, Kurmayer R, Hisbergues M, Dittmann E, Komarek J, et al.
Syst Appl Microbiol
. 2004 Oct;
27(5):592-602.
PMID: 15490561
Microcystis is a well-known cyanobacterial genus frequently producing hepatotoxins named microcystins. Toxin production is encoded by microcystin genes (mcy). This study aims (i) to relate the mcy occurrence in individual...
10.
Rantala A, Fewer D, Hisbergues M, Rouhiainen L, Vaitomaa J, Borner T, et al.
Proc Natl Acad Sci U S A
. 2004 Jan;
101(2):568-73.
PMID: 14701903
Cyanobacteria are a prolific source of secondary metabolites, including compounds with toxic and enzyme-inhibiting activities. Microcystins and nodularins are the end products of a secondary metabolic pathway comprised of mixed...